Click to open contact form.
Your Global Partners in the Business of Innovation

USPTO Program Provides Prioritized Examination for COVID-19 Related Inventions for Small Entities

General / May 12, 2020

The United States Patent and Trademark Office (USPTO) will provide, for no additional fee, prioritized examination for COVID-19 related patent applications for applicants qualifying for small or micro entity status. This special pilot program will waive the fees associated with prioritized examinations, saving small entity applicants $2,000.

To qualify for this pilot program, the claims of the application need to incorporate a product or process subject to FDA approval and related to COVID-19, for instance its treatment and/or prevention.

The USPTO aims to reach final disposition for such applicants within six months (faster than the one-year time frame for typical Track I applications) if applicants respond swiftly to all actions or notices. The initial limit of the pilot program is 500 requests.

More information can be found by contacting Pearl Cohen, and at: